Abstract:Gallic acid (GA) induces apoptosis in different types of cancer cell lines. In this study, we investigate the apoptotic effects induced by GA in human promyelocytic leukemia HL-60 cells, and clarify the underlying mechanism. Our results showed that GA reduced the viability of HL-60 cells in a doseand time-dependent manner. GA led to G0/G1 phase arrest in HL-60 cells through promoting p21 and p27 and inhibiting the levels of cyclin D and cyclin E. GA caused DNA damage and fragmentation in HL-60 cells as assayed using DAPI staining and Comet assay. Flow cytometric analysis revealed that GA increased Ca2+ levels and reduced the mitochondrial membrane potential (ΔΨm) in HL-60 cells. Apoptotic protein expressions were determined by Western blotting. The results indicated that GA-mediated apoptosis of HL-60 cells mainly depended on mitochondrial pathway, by promoting the release of cytochrome c, apoptosis-inducing factor (AIF) and endonuclease G (Endo G) and by upregulating the protein expression of Bcl-2-associated X protein (BAX), caspase-4, caspase-9 and caspase-3. In addition, GA also activated the death receptor-dependent pathway by enhancing the protein expressions of fatty acid synthase (FAS), FAS ligand (FASL), caspase-8 and BCL-2 interacting domain (BID). We determined the mRNA expression of the gene levels of these proteins by real-time PCR. The results showed that GA-mediated apoptosis of HL-60 cells mainly depended on upregulation of the mRNA of caspase-8, caspase-9, caspase-3, AIF and Endo G. In conclusion, GA-induced apoptosis occurs through the death receptor and mitochondria-mediated pathways. The evaluation of GA as a potential therapeutic agent for treatment of leukemia seems warranted. Gallic acid (3,4,5-trihydroxybenzoic acid, GA), an intermediate component of plant (1), has demonstrated antioxidant (2), antibacterial (3), antifungal and antimalarial (4), and antiherpetic action (1). GA was found to induce apoptosis in human leukemia cells (5), lung cancer cell lines (6), stomach cancer cells, colon adenocarcinoma cells (7) and PC12 rat pheochromocytoma cells (8). GA can play an important role in the prevention of malignant transformation (9) and prevents amyloid beta (Aβ)-induced apoptotic neuronal death (10). GA also had antitumor effects on LL-2 (11) and NCI-H460 lung cancer cells both in vitro and in vivo (6). There is no report to show whether GA affects human leukemia HL-60 cells in vitro. In the present study, the effects of GA on the growth and apoptotic cells death of human leukemia HL-60 cells in vitro were investigated. Materials and Methods Chemicals and reagents. GA, propidium iodide (PI), dimethyl sulfoxide (DMSO), ribonuclease A (RNase A), trypan blue and Triton X-100 were obtained from Sigma-Aldrich Corp. (St. Louis, MO, USA). RPMI-1640 medium, trypsin-EDTA, penicillin-streptomycin, 2821 Correspondence to: Jing-Gung Chung, Department of Biological Science and Technology, China Medical University, No. 91, HsuehShih Road, Taichung 404, Taiwan, R.O.C. Tel: +886 422053366 ext. 2161, Fax: +886 422053764, e-mail: jgchung@mail.cmu.edu.tw

Gallic acid as a cancer-selective agent induces apoptosis in pancreatic cancer cells.

Gallic acid induces apoptosis via caspase-3 and mitochondrion-dependent pathways in vitro and suppresses lung xenograft tumor growth in vivo.

Gallic acid induces G₀/G₁ phase arrest and apoptosis in human leukemia HL-60 cells through inhibiting cyclin D and E, and activating mitochondria-dependent pathway.

Gallic Acid Induces Apoptosis in A375.S2 Human Melanoma Cells Through Caspase-Dependent and -Independent Pathways.

Galangin, A Flavonoid From Lesser Galangal, Induced Apoptosis Via P53-Dependent Pathway In Ovarian Cancer Cells

Gallic Acid Hindered Lung Cancer Progression by Inducing Cell Cycle Arrest and Apoptosis in A549 Lung Cancer Cells via PI3K/Akt Pathway

Gallic Acid Induces the Apoptosis of Human Osteosarcoma Cells in Vitro and in Vivo Via the Regulation of Mitogen-Activated Protein Kinase Pathways

Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway

Gallic Acid: A Potential Anti-Cancer Agent

Antiproliferative Effect of Gallic Acid is Mediated via Mitochondrial‐ or ER‐Stress‐Induced Apoptosis and Canonical Autophagy in HT‐29 Cells

Gallic Acid Induces G0/G1 Phase Arrest and Apoptosis in Human Leukemia HL-60 Cells through Inhibiting Cyclin

Gallic Acid Inhibits Bladder Cancer T24 Cell Progression Through Mitochondrial Dysfunction and PI3K/Akt/NF-κB Signaling Suppression

Gallic acid suppresses the progression of triple-negative breast cancer HCC1806 cells via modulating PI3K/AKT/EGFR and MAPK signaling pathways

Ginkgolic Acid Suppresses the Development of Pancreatic Cancer by Inhibiting Pathways Driving Lipogenesis.

Blocking Autophagy Enhances the Apoptotic Effect of 18Β-Glycyrrhetinic Acid on Human Sarcoma Cells Via Endoplasmic Reticulum Stress and JNK Activation

Gallic acid alleviates gastric precancerous lesions through inhibition of epithelial mesenchymal transition via Wnt/β-catenin signaling pathway

Gallic acid suppresses the progression of clear cell renal cell carcinoma through inducing autophagy via the PI3K/Akt/Atg16L1 signaling pathway

Gallic Acid Inhibits The Migration And Invasion Of A375.S2 Human Melanoma Cells Through The Inhibition Of Matrix Metalloproteinase-2 And Ras

Gambogic Acid Lysinate-induced Cervical Cancer SiHa Cells Apoptosis in Vitro and in Vivo

VDAC1 Mediated Anticancer Activity of Gallic Acid in Human Lung Adenocarcinoma A549 Cells.

Gallic Acid Suppressed Tumorigenesis by an LncRNA MALAT1-Wnt/β-Catenin Axis in Hepatocellular Carcinoma